In approximately 50% of human cancers, p53 retains its wild-type (wt) status, but its functions are effectively inhibited by the murine double minute 2 (MDM2) protein through a direct protein–protein interaction [27,28,29,30,31,32,33]. The gene discussed is TP53; the disease is cancer.